accountOncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") announced updated results from a Phase II study of intravenous...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II...
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
